DAVID L MAHONEY
CIK 1224091 · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$145.08M
Companies
3
Total Filings
82
Lifetime Open-Market Net
-$4.95M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Director | 1,267,145 | $114.49 | $145.08M | -$4.95M | 48 | 2026-06-18 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | 0 | $8.22 | $0 | $0 | 12 | 2021-11-24 |
| TERCICA INC (TRCA) Delisted | Director | 3,333 | $7.87 | $26.2K | $0 | 2 | 2008-05-21 |
Recent Filings · Page 3 of 9
82 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-28 | CORT | Grant (A) | — | $0 | EDGAR |
| 2021-05-13 | CORT | Mixed | +23,516 | $2 | EDGAR |
| 2021-03-16 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Exer (M) | +48,000 | $31.9K | EDGAR |
| 2020-06-05 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2020-05-29 | CORT | Grant (A) | — | $0 | EDGAR |
| 2020-05-27 | CORT | Exer (M) | +38,984 | $135.3K | EDGAR |
| 2019-09-18 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Exer (M) | +33,332 | $58.5K | EDGAR |
| 2019-09-13 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-20 | CORT | Grant (A) | — | $0 | EDGAR |
| 2019-06-06 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.